Role of Abl Kinase and the Wave2 Signaling Complex in HIV-1 Entry at a Post-Hemifusion Step

English version České info

Entry of human immunodeficiency virus type 1 (HIV-1) commences with binding of the envelope glycoprotein (Env) to the receptor CD4, and one of two coreceptors, CXCR4 or CCR5. Env-mediated signaling through coreceptor results in Gαq-mediated Rac activation and actin cytoskeleton rearrangements necessary for fusion. Guanine nucleotide exchange factors (GEFs) activate Rac and regulate its downstream protein effectors. In this study we show that Env-induced Rac activation is mediated by the Rac GEF Tiam-1, which associates with the adaptor protein IRSp53 to link Rac to the Wave2 complex. Rac and the tyrosine kinase Abl then activate the Wave2 complex and promote Arp2/3-dependent actin polymerization. Env-mediated cell-cell fusion, virus-cell fusion and HIV-1 infection are dependent on Tiam-1, Abl, IRSp53, Wave2, and Arp3 as shown by attenuation of fusion and infection in cells expressing siRNA targeted to these signaling components. HIV-1 Env-dependent cell-cell fusion, virus-cell fusion and infection were also inhibited by Abl kinase inhibitors, imatinib, nilotinib, and dasatinib. Treatment of cells with Abl kinase inhibitors did not affect cell viability or surface expression of CD4 and CCR5. Similar results with inhibitors and siRNAs were obtained when Env-dependent cell-cell fusion, virus-cell fusion or infection was measured, and when cell lines or primary cells were the target. Using membrane curving agents and fluorescence microscopy, we showed that inhibition of Abl kinase activity arrests fusion at the hemifusion (lipid mixing) step, suggesting a role for Abl-mediated actin remodeling in pore formation and expansion. These results suggest a potential utility of Abl kinase inhibitors to treat HIV-1 infected patients.

Vyšlo v časopise: Role of Abl Kinase and the Wave2 Signaling Complex in HIV-1 Entry at a Post-Hemifusion Step. PLoS Pathog 6(6): e32767. doi:10.1371/journal.ppat.1000956
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1000956

Souhrn

Zdroje

1. GreeneWC

PeterlinBM

2002 Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy. Nature Med 8 673 680

2. GalloSA

2003 The HIV Env-mediated fusion reaction. Biochim Biophys Acta 1614 36 50

3. MiyauchiK

2009 HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell 137 1 12

4. PontowS

HeydenN

WeiS

RatnerL

2004 Actin cytoskeletal reorganizations and coreceptor-mediated activation of Rac during human immunodeficiency virus-induced cell fusion. J Virol 78 7138 7147

5. HarmonB

RatnerL

2008 Induction of the G{alpha}q signaling cascade by the human immunodeficiency virus envelope is required for virus entry. J Virol 82 9191 9205

6. StantchevTS

BroderCC

2001 Human immunodeficiency virus type-1 and chemokines: beyond competition for common cellular receptors. Cytokine Growth Factor Rev 12 219 43

7. BurridgeK

WennerbergK

2004 Rho and Rac take center stage. Cell 116 167 79

8. DebreceniB

2004 Mechanisms of guanine nucleotide exchange and Rac-mediated signaling revealed by a dominant negative Trio mutant. J Biol Chem 279 3777 3786

9. Etienne-MannevilleS

HallA

2002 Rho GTPases in cell biology. Nature 420 629 35

10. PontowSE

HarmonB

CampbellN

RatnerL

2007 Antiviral activity of a Rac GEF inhibitor characterized with a sensitive HIV/SIV fusion assay. Virology 368 1 6

11. GaoY

2004 Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc Natl Acad Sci USA 101 7618 7623

12. SunD

XuD

ZhangB

2006 Rac signaling in tumorigenesis and as target for anticancer drug development. Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy 9 274 287

13. SoderlingSH

ScottJD

2006 Wave signaling: from biochemistry to biology. Biochem Soc Trans 34 73 76

14. KonigR

2002 Interactions between MHC molecules and co-receptors of the TCR. Curr Opin Immunol 14 75 83

15. ConnollyBA

RiceJ

FeigLA

BuchsbaumRJ

2005 Tiam1-IRSp53 complex formation directs specificity of Rac-mediated actin cytoskeleton regulation. Mol Cell Biol 25 4602 4614

16. DerdeynCA

2000 Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 Loop of gp120. J Virol 74 8358 8367

17. WeiX

2002 Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother 46 1896 1905

18. CavroisM

De NoronhaC

GreeneW

2002 A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat Biotechnol 20 1151 1154

19. MeloJV

ChuahC

2008 Novel agents in CML therapy: tyrosine kinase inhibitors and beyond. Hematology 2008 427 435

20. KantarjianHM

GilesF

Quintas-CardamaA

CortesJ

2007 Important therapeutic targets in chronic myelogenous leukemia. Clin Cancer Res 13 1089 1097

21. RoumiantsevS

2002 Clinical resistance to the kinase inhibitor STI-571 in chronic myeloid leukemia by mutation of Tyr-253 in the Abl kinase domain P-loop. Proc Natl Acad Sci USA 99 10700 10705

22. BlumenthalR

1987 pH-dependent fusion of vesicular stomatitis virus with Vero cells. Measurement by dequenching of octadecyl rhodamine fluorescence. J Biol Chem 262 13614 13619

23. RocheS

2008 Structures of vesicular stomatitis virus glycoprotein: membrane fusion revisited. Cell Mol Life Sci 65 1716 1728

24. JohannsdottirH

2008 Host cell factors and functions involved in Vesicular stomatitis virus entry. J Virol

25. BeerC

AndersenDS

RojekA

PedersenL

2005 Caveola-dependent endocytic entry of amphotropic murine leukemia virus. J Virol 79 10776 10787

26. PakC

PuriA

BlumenthalR

1997 Conformational changes and fusion activity of vesicular stomatitis virus glycoprotein: [125I]iodonaphthyl azide photolabeling studies in biological membranes. Biochemistry 36 8890 8896

27. MelikyanG

2008 Common principles and intermediates of viral protein-mediated fusion: the HIV-1 paradigm. Retrovirology 5 111

28. GalloS

2006 Kinetic studies of HIV-1 and HIV-2 envelope glycoprotein-mediated fusion. Retrovirology 3 90

29. MelikyanG

EgelhoferM

von LaerD

2006 Membrane-anchored inhibitory peptides capture human immunodeficiency virus type 1 gp41 conformations that engage the target membrane prior to fusion. J Virol 80 3249 3258

30. ChernomordikL

1998 The pathway of membrane fusion catalyzed by influenza hemagglutinin: restriction of lipids, hemifusion, and lipidic fusion pore formation. J Cell Biol 140 1369 1382

31. ZavorotinskayaT

QianZ

FranksJ

AlbrittonLM

2004 A point mutation in the binding subunit of a retroviral envelope protein arrests virus entry at hemifusion. J Virol 78 473 481

32. MelikyanGB

BrenerSA

OkDC

CohenFS

1997 Inner but not outer membrane leaflets control the transition from glycosylphosphatidylinositol-anchored influenza hemagglutinin-induced hemifusion to full fusion. J Cell Biol 136 995 1005

33. SubramanianRP

GeraghtyRJ

2007 Herpes simplex virus type 1 mediates fusion through a hemifusion intermediate by sequential activity of glycoproteins D, H, L, and B. Proc Natl Acad Sci USA 104 2903 2908

34. Jimenez-BarandaS

2007 Filamin-A regulates actin-dependent clustering of HIV receptors. Nat Cell Biol 9 838 846

35. IyengarS

HildrethJ

SchwartzD

1998 Actin-dependent receptor colocalization required for human immunodeficiency virus entry into host cells. J Virol 72 5251 5255

36. del RealG

2004 Statins inhibit HIV-1 infection by down-regulating Rho activity. J Exp Med 200 541 547

37. GalloS

PuriA

BlumenthalR

2001 HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process. Biochemistry 40 12231 12236

38. ViardM

2002 Role of cholesterol in human immunodeficiency virus type 1 envelope protein-mediated fusion with host cells. J Virol 76 11584 11595

39. LambertJM

2002 Tiam1 mediates Ras activation of Rac by a PI(3)K-independent mechanism. Nat Cell Biol 4 621 625

40. ViardM

2004 The role of glycosphingolipids in HIV signaling, entry and pathogenesis. Glycoconj J 20 213 222

41. ZandyNL

PendergastAM

2008 Abl tyrosine kinases modulate cadherin-dependent adhesion upstream and downstream of Rho family GTPases. Cell Cycle 7 444 448

42. ZandyNL

PlayfordM

PendergastAM

2007 Abl tyrosine kinases regulate cell-cell adhesion through Rho GTPases. Proc Natl Acad Sci USA 104 17686 17691

43. PraefckeGJK

McMahonHT

2004 The dynamin superfamily: universal membrane tubulation and fission molecules? 5 133 147

44. YuD

2009 The HIV Envelope but Not VSV Glycoprotein Is Capable of Mediating HIV Latent Infection of Resting CD4 T Cells. PLoS Pathog 5 e1000633

45. KruegerEW

OrthJD

CaoH

McNivenMA

2003 A Dynamin-Cortactin-Arp2/3 Complex Mediates Actin Reorganization in Growth Factor-stimulated Cells. Mol Biol Cell 14 1085 1096

46. BackertS

FellerSM

WesslerS

2008 Emerging roles of Abl family tyrosine kinases in microbial pathogenesis. Trends in Biochemical Sciences 33 80 90

47. SwinglerS

2007 Apoptotic killing of HIV-1 infected macrophages is subverted by the viral envelope glycoprotein. PLoS Pathog 3 e134

48. PontowS

RatnerL

2001 Evidence for common structural determinants of human immunodeficiency virus type 1 coreceptor activity provided through functional analysis of CCR5/CXCR4 chimeric coreceptors. J Virol 75 11503 11514